Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells

Cisplatin is still the primary therapeutic choice for advanced lung cancers without driver mutations. The occurrence of cisplatin resistance is a major clinical problem in lung cancer treatment. The natural extracted agent emetine reportedly has anticancer effects. This study aimed to explore the po...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ti-Hui, Chang, Shan-Yueh, Shih, Yu-Lueng, Huang, Tsai-Wang, Chang, Hung, Lin, Ya-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928603/
https://www.ncbi.nlm.nih.gov/pubmed/31775307
http://dx.doi.org/10.3390/ijms20235914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928603/
https://www.ncbi.nlm.nih.gov/pubmed/31775307
http://dx.doi.org/10.3390/ijms20235914

Ejemplares similares